Navigation Links
Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
Date:7/27/2012

LOS ANGELES, July 27, 2012 /PRNewswire/ -- Intrepid Investment Bankers LLC ("Intrepid"), a leading middle market investment banking firm, today announced the sale of the specialty pharmacy assets of A-Med Health Care ("A-Med") to Modern HC Pharmacy, Inc. ("Modern"), a newly formed portfolio company of Altamont Capital Partners ("ACP").  The transaction closed on July 24, 2012. Intrepid acted as the exclusive M&A advisor to A-Med in connection with the specialty pharmacy asset sale. 

(Logo:  http://photos.prnewswire.com/prnh/20120315/LA70428LOGO)

Founded in 1982 and headquartered in Huntington Beach, California, A-Med is a leading provider of medical supplies and specialty pharmaceuticals to patients throughout the United States.  A-Med's specialty pharmacy operation principally services Medicare, Medicaid / Medi-Cal and managed care patients across several disease states including, cystic fibrosis, HIV / AIDS and transplant patients.

Modern is a newly formed entity created to combine the specialty pharmacy assets of A-Med with the specialty pharmacy assets of Modern HEALTHcare, Inc., which provides long-term care medication programs for skilled nursing and assisted living communities and specialized pharmacy services to individuals challenged with a broad range of chronic health conditions.  ACP is a private equity sponsor based in the San Francisco Bay area with $500 million in capital, focused on investing in change-intensive middle market businesses across several industries, including healthcare.

Ed Bagdasarian, Managing Director of Intrepid, commented, "We were pleased to have the opportunity to work closely with the owners and management team of A-Med through the sale process.  After starting the specialty pharmacy in 2003 and growing it considerably, the owners of A-Med decided to pursue  its divestiture so that A-Med could focus on building its core medical supplies business.  The transaction represented the culmination of a complex three-party combination that best achieves the objectives of A-Med's owners and allows management to focus on driving the growth of its medical supplies unit.  This transaction continues our team's long track record of completing successful transactions in the healthcare sector."

"We are very appreciative of the work done by the team at Intrepid.  This was a highly complex transaction and Intrepid demonstrated a thorough understanding of our business needs and the unique aspects of a specialty pharmacy in today's changing healthcare environment," said Larry Thacker, President and CEO of A-Med.  "We are pleased to be selling the specialty pharmacy assets to Modern and ACP and wish them the best of luck in achieving their objectives and goals."

The Intrepid team included Ed Bagdasarian, Gary Rabishaw, Jeremiah Mann, Shahriar Attaie and Chris Neils.

About Intrepid Investment Bankers LLC 

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. Intrepid's services include M&A advisory, equity and debt capital raising and providing strategic advice in complex securities transactions. The firm focuses on the middle market corporate finance needs of entrepreneur and family-owned businesses, private equity sponsors and major corporations. Collectively, the senior team at Intrepid brings over 150 years of mergers and acquisitions advisory experience and has advised on over 250 transactions spanning a broad range of industries, including consumer products and services, industrial manufacturing, healthcare products and services, building products, business services and retail. www.intrepidib.com Member FINRA/SIPC. 


'/>"/>
SOURCE Intrepid Investment Bankers LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
2. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
5. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
6. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
7. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
8. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
9. Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
10. Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
11. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/29/2017)... 29, 2017 In a move that promises ... compliance for veterinary practices of all sizes, Cubex LLC ... that makes TITAN,s expertise in physical security, drug diversion ... clients nationally. ... controlled substances is at risk today," said TITAN founder ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two ... in excess of $835 million in resolved debt for its clients. , Credit card ... of the categories of debt settled by the company. With more than a decade ...
(Date:9/19/2017)... ... September 19, 2017 , ... Arizona-based ... as the President of its HealthBI division. McFarland will grow the organization’s ... , “Scott is a utility player who balances his day as a ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a new ... we’re born, Nature gives us a full supply of melanin – in the back ... this natural glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown ...
(Date:9/19/2017)... ... September 19, 2017 , ... Presenting its annual ... (SPBA) hosted “Expanding Your Success” with an educational emphasis. , The three-day ... best practices for third party administrators (TPAs) related to health plan management and ...
Breaking Medicine News(10 mins):